← Back to RGEN

Repligen Corporation financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 29/07/2026Mar 2026Filed 06/05/2026Sep 2025Filed 04/11/2025Jun 2025Filed 29/07/2026Mar 2025Filed 06/05/2026Sep 2024Filed 04/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 29/04/2025
$204$194$189$182$169$155$159$153
$5$8.3$15$15$5.8−$0.7$5.7$3.3
$0.09$0.15$0.26$0.26$0.10−$0.01$0.10$0.06
57575757

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.